BYND — Beyond Meat, Inc.
Is BYND overbought or oversold? Here is the current MarketMoodz read.
Beyond Meat, Inc. (BYND) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Defensive name (Packaged Foods) last closed at $4.95. The rating moved from Strong Oversold to Oversold on November 10, 2026.
- Public ratingOversold (as of November 17, 2026)
- Last close$4.95
- Last changeMoved from Strong Oversold to Oversold on November 10, 2026
- SectorConsumer Defensive
- IndustryPackaged Foods
See all oversold Consumer Defensive stocks →
AI analysis
Beyond Meat, Inc. (BYND) combines strong brand recognition in plant-based proteins with meaningful execution risk. Financial health remains fragile given historical losses and cash consumption, though margin improvement programs and product innovation offer a path to stabilization if retail and foodservice placement convert to repeat sales. Competitive pressure from large incumbents and price-sensitive consumers, plus commodity cost volatility, create downside risk and potential dilution if external financing is needed. Near-term price action will likely be driven by distribution wins, quarterly results, and visible progress on manufacturing efficiency.
Key factors
- Brand recognition and early-mover status in plant‑based proteins provide differentiated consumer awareness and retail/foodservice placements.
- Revenue recovery potential from new product innovation, partnerships, and targeted foodservice accounts if execution and placement improve.
- Ongoing cost-reduction and manufacturing scale initiatives could materially improve gross margins if realized.
- Sector-level reinvestment and product-innovation tailwinds across packaged foods could create favorable readthroughs for alternative-protein offerings.
- Current market tone favors growth names, which may support episodic upside on positive earnings or distribution news.
Risks
- Persistent negative earnings and constrained free‑cash‑flow; continued cash burn may require dilutive financing or asset sales.
- Intense competition from incumbent food companies, private labels and low-cost protein alternatives, pressuring pricing and share.
- Execution risk on scaling production, improving margins, and converting trial into repeat purchases at retail and foodservice.
- Commodity and input-cost volatility (peas, oils, packaging) that can compress margins if not passed through to consumers.
- Weak consumer demand sensitivity to price and taste vs. animal-protein alternatives could limit growth.
- Volatile stock price and low liquidity episodes increasing investor sensitivity to short-term news and potential delisting or governance pressures.
See today's live rating, score and targets
Members see the live hourly rating for BYND — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.